Cargando…

A Comparison of Two Short-Course Primaquine Regimens for the Treatment and Radical Cure of Plasmodium vivax Malaria in Thailand

Thai adult males (N = 85) with acute Plasmodium vivax malaria and normal glucose-6-phosphate dehydrogenase screening were randomized to receive 30 mg or 60 mg primaquine daily for 7 days (N = 43 and 42, respectively). The regimens were well tolerated and all patients recovered fully. Median fever cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pukrittayakamee, Sasithon, Imwong, Mallika, Chotivanich, Kesinee, Singhasivanon, Pratap, Day, Nicholas P. J., White, Nicholas J.
Formato:	Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2010
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844579/ https://www.ncbi.nlm.nih.gov/pubmed/20348496 http://dx.doi.org/10.4269/ajtmh.2010.09-0428

Ejemplares similares

Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2019)

Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border
por: Takeuchi, Rie, et al.
Publicado: (2010)

Genetic diversity of Plasmodium vivax in Kolkata, India
por: Kim, Jung-Ryong, et al.
Publicado: (2006)

Plasmodium vivax Adherence to Placental Glycosaminoglycans
por: Chotivanich, Kesinee, et al.
Publicado: (2012)

The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin–piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos
por: Pongvongsa, Tiengkham, et al.
Publicado: (2018)

Epidemiology of Plasmodium vivax Malaria Infection in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2018)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature
por: John, George K, et al.
Publicado: (2012)

The effects of serum lipids on the in vitro activity of lumefantrine and atovaquone against Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2012)

K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
por: Win, Aye A., et al.
Publicado: (2016)

Erratum to: K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
por: Win, Aye A., et al.
Publicado: (2016)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
por: Awab, Ghulam Rahim, et al.
Publicado: (2010)

Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1
por: Imwong, Mallika, et al.
Publicado: (2005)

Active Pharmacovigilance for Primaquine Radical Cure of Plasmodium vivax Malaria in Odisha, India
por: Anvikar, Anupkumar R., et al.
Publicado: (2022)

Genotyping of Plasmodium vivax Reveals Both Short and Long Latency Relapse Patterns in Kolkata
por: Kim, Jung-Ryong, et al.
Publicado: (2012)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023)

Limited Polymorphism of the Kelch Propeller Domain in Plasmodium malariae and P. ovale Isolates from Thailand
por: Nakeesathit, Supatchara, et al.
Publicado: (2016)

Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters
por: Popovici, Jean, et al.
Publicado: (2021)

Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax
por: Rajgor, D. D., et al.
Publicado: (2014)

Genetic analysis of the orthologous crt and mdr1 genes in Plasmodium malariae from Thailand and Myanmar
por: Pimpat, Yupawadee, et al.
Publicado: (2020)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
por: Taylor, Walter R J, et al.
Publicado: (2019)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
por: Watson, James, et al.
Publicado: (2018)

Declining Burden of Plasmodium vivax in a Population in Northwestern Thailand from 1995 to 2016 before Comprehensive Primaquine Prescription for Radical Cure
por: Chu, Cindy S., et al.
Publicado: (2020)

Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials
por: Phommasone, Koukeo, et al.
Publicado: (2020)

Chloroquine–Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial
por: Awab, Ghulam Rahim, et al.
Publicado: (2017)

Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure
por: Olvany, Jasmine M., et al.
Publicado: (2022)

The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
por: von Seidlein, Lorenz, et al.
Publicado: (2019)

A Randomized Comparison of Dihydroartemisinin-Piperaquine and Artesunate-Amodiaquine Combined With Primaquine for Radical Treatment of Vivax Malaria in Sumatera, Indonesia
por: Pasaribu, Ayodhia Pitaloka, et al.
Publicado: (2013)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
por: Phyo, Aung Pyae, et al.
Publicado: (2016)

Therapeutic Assessment of Primaquine for Radical Cure of Plasmodium vivax Malaria at Primary and Tertiary Care Centres in Southwestern India
por: Kumar, Rishikesh, et al.
Publicado: (2016)

Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2014)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
por: Taylor, Walter Robert, et al.
Publicado: (2021)

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018)

Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon
por: Graf, Paul C. F., et al.
Publicado: (2012)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy
por: Goh, Yun Shan, et al.
Publicado: (2016)

Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses
por: Yilma, Daniel, et al.
Publicado: (2023)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

Adherence to 7-Day Primaquine Treatment for the Radical Cure of P. vivax in the Peruvian Amazon
por: Grietens, Koen Peeters, et al.
Publicado: (2010)

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan
por: Awab, Ghulam R, et al.
Publicado: (2013)

Artemisinin resistance and malaria elimination: Where are we now?
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ovohkd6pmsileuufkfk7is7va8